For example, Song S. et al. demonstrated that increased concentrations of bFGF in the conditioned medium of solid and metastatic tumors might mediate their resistance to certain chemotherapeutic agents—paclitaxel, doxorubicin, and 5-fluorouracil—whereas the inhibition of bFGF by monoclonal antibody abolished this effect [44]. The gene discussed is FGF2; the disease is metastatic neoplasm.